← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Gateway Bio, Inc.
Durham, NC
$2,461,707
Total funding
5
Grants
Funding over time
peak $1.3M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,461,707 · 5
By mechanism
R44$1,278,585 · 1
R41$1,183,122 · 4
Investigators at Gateway Bio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Scale-up and Toxicity Studies of POEGMA-Uricase$639,413
R44 · FY2025 · TR
Scale-up and Toxicity Studies of POEGMA-Uricase$639,172
R44 · FY2024 · TR
Next Generation Stealth Lipid for the Delivery of mRNA$314,347
R41 · FY2025 · AI
Novel Stealth Lipid for use in HIV MPER Vaccine$303,173
R41 · FY2025 · AI
Non-Immunogenic PEG-like Conjugates of Uricase$288,472
R41 · FY2020 · TR
Development of a POEGMA-Aptamer rapid onset anticoagulant that eliminates antigenicity to anti-PEG antibodies$277,130
R41 · FY2017 · HL